Nystatin oral gel and preparation method thereof
By combining acupuncture nystatin with hydroxyethyl cellulose and moisturizer, and adding antibacterial and flavoring agents, the problems of stability and uniformity of oral gels in the prior art are solved, and a A highly efficient and stable oral gel suitable for infants and young children, improving the compliance and antibacterial effect of treatment.
Patent Information
- Application Number
- CN202311731925.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-15
- Publication Date
- 2024-11-29
AI Technical Summary
The existing nystatin oral gels have shortcomings in stability and uniformity of properties, and their viscosity changes greatly, making it difficult to meet the needs of high-quality local drug delivery, especially in the treatment of oral diseases in infants and young children.
Using acupuncture nystatin, ethyl hydroxycellulose as the matrix, glycerin or propylene glycol as the moisturizing agent, and adding antibacterial agent, flavoring agent and fragrance agent to form a stable oral gel through specific preparation methods to ensure moderate viscosity. No obvious bitter taste, which improves drug compliance and antibacterial effect.
It has achieved stable quality of nystatin oral gel, no obvious changes in viscosity, good taste, strong antibacterial ability, and suitable for oral use in infants and young children, improving the compliance and effect of treatment.
Smart Images

Figure BDA0004610512710000041 
Figure BDA0004610512710000042 
Figure BDA0004610512710000052
Abstract
Description
Technical Field
[0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to a nystatin oral gel and a preparation method thereof. Background Art
[0002] Thrush, also known as snow mouth disease and albicans, is a common oral disease in children caused by fungal infection. White patches form on the surface of the oral mucosa, which is more common in infants and young children. The disease is caused by infection with Candida albicans. This fungus can sometimes be found in the mouth, and can occur when infants are malnourished or physically weak. Candida albicans can also be often found in the mouths of healthy children, but it is not pathogenic. With the widespread use of antibiotics and other immunosuppressants in clinical practice, dysbiosis or reduced immunity leading to albicans candidiasis is becoming more and more common in clinical practice, and its treatment has become a hot issue. At present, the first-line drug for the clinical treatment of oral candidiasis is the antifungal antibiotic nystatin.
[0003] Nystatin is a polyene antifungal drug with a broad-spectrum antifungal effect. It has been used as the first choice for oral candidiasis and thrush in European and American countries, and can also be used for the treatment of enteritis. Due to its good safety and efficacy, it has a good clinical application, especially for high-risk groups such as infants and young children. Since nystatin is not absorbed in the body, the blood concentration after oral administration is extremely low, and it has no therapeutic effect on systemic fungal infections, it is not suitable for injection. At present, the main dosage form of nystatin on the market is tablets. Therefore, it is urgent to develop a stable nystatin pharmaceutical composition that can be used for local administration to improve patient compliance.
[0004] The prior art discloses a nystatin vaginal gel. Due to the special treatment site of the preparation, the problems of taste masking and taste correction are not considered, which are precisely the key points in the development of oral gels. In the prior art, CN108324681A discloses a nystatin oral gel. The gel uses a gel enhancer acrylic resin to form a firm spatial structure with hydroxyethyl cellulose, which has thickening, adhesive and plasticizing effects on the gel. However, in the actual preparation, there are the following problems: the acrylic resin is not easy to disperse, the reaction with hydroxyethyl cellulose is not complete, and the viscosity changes greatly during the stability placement process. Patent CN110302145A discloses a method for preparing a nystatin oral gel with a shortened production cycle and stable characteristics. A dispersing aid is used to assist the swelling of hydroxyethyl cellulose to shorten the preparation time. The viscosity value of the prepared sample is small, and the residence time when applied to the oral affected area is short.
[0005] In summary, the existing products and technologies cannot fully realize the production of stable nystatin oral gel products with uniform properties. In order to provide a product with stable quality, the inventors have found through a large number of experiments that the nystatin oral gel produced by combining needle-shaped nystatin crystals, a matrix and a humectant in the present invention can be further added with one or more of a flavoring agent, an antibacterial agent, a fragrance and water. The obtained oral gel has stable properties and no significant change in viscosity. Summary of the invention
[0006] In one aspect, the present invention provides an oral gel of nystatin, characterized in that the oral gel comprises nystatin, a base and a moisturizer.
[0007] Preferably, the nystatin crystals are needle-shaped.
[0008] Preferably, the matrix is hydroxyethyl cellulose, more preferably, the matrix is one or more of hydroxyethyl cellulose 250G, hydroxyethyl cellulose 250M, hydroxyethyl cellulose 250HX, more preferably hydroxyethyl cellulose 250M.
[0009] Preferably, the humectant is one or more of glycerol and propylene glycol.
[0010] Preferably, the mass percentage of nystatin in the oral gel is 0.01% to 5%, preferably 05% to 3%, more preferably 0.8% to 2%, and more specifically 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2.0%.
[0011] Preferably, the matrix accounts for 0.01% to 5% of the total mass percentage, preferably 0.5% to 2%, preferably 0.8% to 1.2%, more specifically 0.8%, 0.9%, 1.0%, 1.1%, 1.2%.
[0012] Preferably, the mass percentage of the moisturizing agent in the total amount is 0.01% to 30%, preferably 0.5% to 25%, preferably 1% to 20%, preferably 10% to 20%, more specifically 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%.
[0013] Preferably, the oral gel further comprises an antibacterial agent. Preferably, the antibacterial agent is selected from one or more of methylparaben, ethylparaben, propylparaben, butylparaben, and sodium methylparaben. Preferably, the mass percentage of the antibacterial agent in the total amount is 0.01% to 1.0%, preferably 0.05% to 0.5%, preferably 0.1% to 0.3%, and more specifically 0.1%, 0.2%, or 0.3%.
[0014] Preferably, the oral gel further comprises a flavoring agent; preferably, the flavoring agent is selected from one or more of sucrose, sorbitol, and xylitol; preferably, the mass percentage of the flavoring agent in the total amount is 0.01% to 70%, preferably 5% to 65%, preferably 10% to 65%, preferably 20% to 60%, preferably 30% to 60%, more preferably 40% to 50%, and more specifically 40%, 45%, and 50%.
[0015] Preferably, the oral gel further comprises a fragrance; preferably, the fragrance is selected from one or more of strawberry essence, raspberry essence, banana essence, orange essence, cinnamaldehyde, mint, and raspberry essence. Preferably, the mass percentage of the fragrance in the total amount is 0.01% to 1.0%, preferably 0.1% to 0.5%, more specifically 0.1%, 0.2%, 0.3%, 0.4%, 0.5%.
[0016] Preferably, the oral gel further comprises purified water.
[0017] Preferably, in certain embodiments of the present invention, nystatin is Figure 2 The spiculate mycin shown.
[0018] The percentages in the examples are by mass unless otherwise specified.
[0019] Unless otherwise specified, all numbers used in this specification and claims to indicate content, concentration, ratio, weight, percentage, technical effect, etc. should be understood as modified by the term "about" or "approximately" in any case. "About" represents a range of ±10% of the value it modifies, preferably a range of ±5%.
[0020] The present invention also relates to a method for preparing a nystatin oral gel, comprising: first preparing a flavoring solution with a flavoring agent, an antibacterial agent and purified water; after a matrix is dispersed in a humectant, the matrix is added into the flavoring solution for swelling and dispersion; nystatin is separately dispersed in purified water to form a suspension; the suspension and the aromatic agent are then stirred or ground and mixed with the matrix solution to uniformly suspend and disperse the nystatin in the matrix.
[0021] On the other hand, the present invention also relates to the use of any of the above-mentioned oral gels in the preparation of medicaments for treating thrush oral diseases in infants and young children.
[0022] Beneficial Effects
[0023] The present invention has found through a large number of experiments that the oral gel of nystatin of the present invention has a fruity aroma, no obvious bitterness, moderate viscosity, stable quality, strong antibacterial ability, and is equipped with a cotton swab, which can evenly apply the drug to the affected part of the oral cavity of infants and young children for safe, fast and accurate drug administration, thereby greatly improving the patient compliance of goose oral drug treatment.
[0024] The present invention also provides a method for preparing the oral gel of nystatin, so that nystatin can achieve the maximum antibacterial effect in the oral cavity. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 This is a microscope image of rod-shaped nystatin in the example
[0026] Figure 2 This is a microscope image of needle-shaped nystatin in the example DETAILED DESCRIPTION
[0027] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0028] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.
[0029] Example 1 Nystatin Oral Gel
[0030] Weigh the raw and auxiliary materials according to Table 1-1.
[0031] (1) Preparation of flavoring solution: Add the antibacterial agent and flavoring agent in order to about 50% of the prescribed amount of purified water, heat at 80°C and stir to dissolve;
[0032] (2) Preparation of gel solution: Disperse the matrix in the moisturizer, add it to the flavoring agent solution, stir and disperse at 75 rpm, then add about 20% of the prescription amount of purified water, stir at 75 rpm and shear at 3000 rpm for 30 min, disperse and swell to form a gel solution, and then cool to below 40°C;
[0033] (3) Main drug suspension: Add nystatin to about 20% of the prescription amount of purified water, moisten, and stir to form a suspension solution;
[0034] (4) Molding: Add the main drug suspension, fragrance, etc. to the gel solution, evacuate to below 0.08 MPa, stir and shear at a stirring speed of 75 rpm and a shear speed of 3000 rpm for 30 minutes, and continue stirring and evacuating until there are no obvious bubbles to obtain a suspension gel.
[0035] Table 1-1 Oral gels of different nystatin APIs
[0036]
[0037] The appearance and smell of the samples in Table 1-1 were observed, and the pH, viscosity (instrument: Shanghai Nirun NTV-T1 viscometer, No. 14 rotor, speed 5 rpm, measurement time 5 min, measurement temperature 25°C), and taste were tested. The results are shown in the following table:
[0038] Table 1-2 Sample test results
[0039] sample Appearance odor pH Viscosity taste 1001 Uniform yellow viscous Fruity aroma 6.2 15200mPa·s No obvious bitter taste 1002 Uniform yellow viscous Fruity aroma 6.3 15000mPa·s No obvious bitter taste 1003 Uniform yellow viscous Fruity aroma 6.2 15600mPa·s No obvious bitter taste 1004 Uniform yellow viscous Fruity aroma 6.1 16100mPa·s No obvious bitter taste 1005 Uniform yellow viscous Fruity aroma 6.3 17800mPa·s No obvious bitter taste 1006 Uniform yellow viscous Fruity aroma 6.2 15350mPa·s No obvious bitter taste 1007 Uniform yellow viscous Fruity aroma 6.2 15750mPa·s No obvious bitter taste 1008 Uniform yellow viscous Fruity aroma 6.3 15100mPa·s No obvious bitter taste
[0040] The samples in Table 1-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0041] Table 1-3 Test results of samples after 5 days of high temperature reaction
[0042]
[0043]
[0044] The samples in Table 1-1 were placed in a 40°C oven and the results of the observations for 10 days are shown in the following table:
[0045] Table 1-4 Test results of samples after 10 days of high temperature reaction
[0046] sample Appearance odor pH Viscosity taste 1001 Yellow viscous Fruity aroma 6.0 21250mPa·s No obvious bitter taste 1002 Yellow viscous Fruity aroma 6.1 21500mPa·s No obvious bitter taste 1003 Yellow viscous Fruity aroma 6.1 21900mPa·s No obvious bitter taste 1004 Yellow viscous Fruity aroma 6.1 22150mPa·s No obvious bitter taste 1005 Yellow viscous Fruity aroma 6.1 22850mPa·s No obvious bitter taste 1006 Yellow viscous Fruity aroma 6.0 20575mPa·s No obvious bitter taste 1007 Yellow viscous Fruity aroma 6.2 20900mPa·s No obvious bitter taste 1008 Yellow viscous Fruity aroma 6.0 15500mPa·s No obvious bitter taste
[0047] The results showed that when the active ingredient was in the form of rod-shaped crystals, the viscosity of the sample increased significantly after 5 and 10 days at a high temperature of 40°C by changing the active ingredient content, glycerol dosage, propylene glycol dosage, and sucrose dosage. However, when the active ingredient was in the form of needle-shaped crystals, the viscosity of the sample did not increase significantly after 5 and 10 days at a high temperature of 40°C.
[0048] Example 2 Investigation of different types of moisturizers and their contents
[0049] Weigh the raw materials and auxiliary materials according to Table 2-1, and prepare the corresponding samples in the same way as Example 1.
[0050] Table 2-1 Oral gels with different types of moisturizers and their contents
[0051]
[0052] The appearance and smell of the samples in Table 2-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0053] Table 2-2 Sample test results
[0054]
[0055]
[0056] The samples in Table 2-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0057] Table 2-3 Test results of samples after 5 days of high temperature reaction
[0058] sample Appearance odor pH Viscosity taste 1009 Yellow viscous Fruity aroma 6.3 15200mPa·s No obvious bitter taste 1010 Yellow viscous Fruity aroma 6.2 15350mPa·s No obvious bitter taste 1011 Yellow viscous Fruity aroma 6.2 15100mPa·s No obvious bitter taste 1012 Yellow viscous Fruity aroma 6.1 15500mPa·s No obvious bitter taste 1013 Yellow viscous Fruity aroma 6.0 15900mPa·s No obvious bitter taste 1014 Yellow viscous Fruity aroma 6.2 15575mPa·s No obvious bitter taste 1015 Yellow viscous Fruity aroma 6.1 16100mPa·s No obvious bitter taste 1016 Yellow viscous Fruity aroma 6.3 15900mPa·s No obvious bitter taste 1017 Yellow viscous Fruity aroma 6.1 15400mPa·s No obvious bitter taste 1018 Yellow viscous, with layers Fruity aroma 6.2 7500mPa·s No obvious bitter taste
[0059] The results showed that when the content of glycerol or propylene glycol was within the range of 10% to 20%, the appearance, smell, pH, viscosity, taste, etc. of the prepared samples showed no obvious changes under high temperature conditions of 40°C for 5 days; while when there was no glycerol or propylene glycol in the prescription, the appearance and viscosity of the prepared samples changed under high temperature conditions of 40°C for 5 days, there was stratification in the appearance, and the viscosity decreased, indicating that when the content of glycerol or propylene glycol in the prescription of the present invention was within the range of 10% to 20%, the physical properties of the prescription samples changed little.
[0060] Example 3 Investigation of different types of matrices and their contents
[0061] Weigh the raw and auxiliary materials according to Table 3-1, and prepare the corresponding samples in the same way as Example 1.
[0062] Table 3-1 Oral gels with different types of bases and contents
[0063]
[0064] The appearance and smell of the samples in Table 3-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0065] Table 3-2 Sample test results
[0066] sample Appearance odor pH Viscosity taste 1019 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1020 Yellow viscous Fruity aroma 6.2 13200mPa·s No obvious bitter taste 1021 Yellow viscous Fruity aroma 6.2 17000mPa·s No obvious bitter taste 1022 Yellow viscous Fruity aroma 6.1 17200mPa·s No obvious bitter taste 1023 Yellow viscous Fruity aroma 6.3 15400mPa·s No obvious bitter taste 1024 Yellow viscous Fruity aroma 6.3 19300mPa·s No obvious bitter taste 1025 Yellow viscous Fruity aroma 6.2 11500mPa·s No obvious bitter taste 1026 Yellow viscous Fruity aroma 6.3 14800mPa·s No obvious bitter taste 1027 Yellow viscous Fruity aroma 6.1 15500mPa·s No obvious bitter taste 1028 Yellow viscous Fruity aroma 6.3 15000mPa·s No obvious bitter taste
[0067] The samples in Table 3-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0068] Table 3-3 Test results of samples after 5 days of high temperature reaction
[0069] sample Appearance odor pH Viscosity taste 1019 Yellow viscous Fruity aroma 6.1 15000mPa·s No obvious bitter taste 1020 Yellow viscous Fruity aroma 6.2 13100mPa·s No obvious bitter taste 1021 Yellow viscous Fruity aroma 6.2 17100mPa·s No obvious bitter taste 1022 Yellow viscous Fruity aroma 6.1 17400mPa·s No obvious bitter taste 1023 Yellow viscous Fruity aroma 6.3 15100mPa·s No obvious bitter taste 1024 Yellow viscous Fruity aroma 6.3 19300mPa·s No obvious bitter taste 1025 Yellow viscous, slightly layered Fruity aroma 6.2 11200mPa·s No obvious bitter taste 1026 Yellow viscous, slightly stratified Fruity aroma 6.3 10200mPa·s No obvious bitter taste 1027 Yellow viscous, slightly stratified Fruity aroma 6.1 10500mPa·s No obvious bitter taste 1028 Yellow viscous, slightly stratified Fruity aroma 6.3 11000mPa·s No obvious bitter taste
[0070] The results showed that when the content of hydroxyethyl cellulose 250M was in the range of 0.8% to 1.2%, the appearance, odor, pH, viscosity, taste and other aspects of the prepared samples did not change significantly at high temperature; when the content of hydroxyethyl cellulose 250HX was in the range of 0.8% to 1.2%, the appearance, odor, pH, viscosity, taste and other aspects of the prepared samples did not change significantly at high temperature; the viscosity of the samples prepared using hydroxypropyl cellulose, hydroxypropyl methylcellulose and carboxymethyl cellulose decreased significantly after being exposed to high temperature of 40°C for 5 days, and there was stratification in appearance.
[0071] Example 4 Investigation of different types of antibacterial agents and their contents
[0072] Weigh the raw materials and auxiliary materials according to Table 4-1, and prepare the corresponding samples in the same way as Example 1.
[0073] Table 4-1 Oral gels with different types and contents of antibacterial agents
[0074]
[0075]
[0076] The appearance and smell of the samples in Table 4-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0077] Table 4-2 Sample test results
[0078] sample Appearance odor pH Viscosity taste 1029 Yellow viscous Fruity aroma 6.2 15200mPa·s No obvious bitter taste 1030 Yellow viscous Fruity aroma 6.3 15000mPa·s No obvious bitter taste 1031 Yellow viscous Fruity aroma 6.2 15300mPa·s No obvious bitter taste 1032 Yellow viscous Fruity aroma 6.2 15125mPa·s No obvious bitter taste 1033 Yellow viscous Fruity aroma 6.3 15250mPa·s No obvious bitter taste 1034 Yellow viscous Fruity aroma 6.1 15300mPa·s No obvious bitter taste 1035 Yellow viscous Fruity aroma 6.2 15400mPa·s No obvious bitter taste 1036 Yellow viscous Fruity aroma 6.1 15300mPa·s No obvious bitter taste
[0079] The samples in Table 4-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0080] Table 4-3 Test results of samples after 5 days of high temperature reaction
[0081] sample Appearance odor pH Viscosity taste 1029 Yellow viscous Fruity aroma 6.0 15125mPa·s No obvious bitter taste 1030 Yellow viscous Fruity aroma 6.2 15000mPa·s No obvious bitter taste 1031 Yellow viscous Fruity aroma 6.1 15100mPa·s No obvious bitter taste 1032 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1033 Yellow viscous Fruity aroma 6.2 15100mPa·s No obvious bitter taste 1034 Yellow viscous Fruity aroma 6.3 15100mPa·s No obvious bitter taste 1035 Yellow viscous Fruity aroma 6.0 15500mPa·s No obvious bitter taste 1036 Yellow viscous Fruity aroma 6.2 15000mPa·s No obvious bitter taste
[0082] The results showed that the content of antibacterial agents methylparaben + propylparaben, ethylparaben + butylparaben, and sodium methylparaben was within the range of 0.1% to 0.3%. The prepared samples were exposed to high temperature at 40°C for 5 days, and there was no significant change in appearance, smell, pH, viscosity, taste, etc.
[0083] Weigh the raw and auxiliary materials according to Table 5-1, and prepare the corresponding samples in the same way as Example 1.
[0084] Table 5-1 Oral gels with different types of flavoring agents and their contents
[0085]
[0086]
[0087] The appearance and smell of the samples in Table 5-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0088] Table 5-2 Sample test results
[0089] sample Appearance odor pH Viscosity taste 1037 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1038 Yellow viscous Fruity aroma 6.2 14400mPa·s No obvious bitter taste 1039 Yellow viscous Fruity aroma 6.2 15700mPa·s No obvious bitter taste 1040 Yellow viscous Fruity aroma 6.3 14900mPa·s No obvious bitter taste 1041 Yellow viscous Fruity aroma 6.1 14200mPa·s No obvious bitter taste 1042 Yellow viscous Fruity aroma 6.3 15600mPa·s No obvious bitter taste 1043 Yellow viscous Fruity aroma 6.2 15300mPa·s No obvious bitter taste 1044 Yellow viscous Fruity aroma 6.2 14200mPa·s No obvious bitter taste 1045 Yellow viscous Fruity aroma 6.1 15750mPa·s No obvious bitter taste
[0090] The samples in Table 5-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0091] Table 5-3 Test results of samples after 5 days of high temperature reaction
[0092] sample Appearance odor pH Viscosity taste 1037 Yellow viscous Fruity aroma 6.2 15250mPa·s No obvious bitter taste 1038 Yellow viscous Fruity aroma 6.1 14200mPa·s No obvious bitter taste 1039 Yellow viscous Fruity aroma 6.0 15800mPa·s No obvious bitter taste 1040 Yellow viscous Fruity aroma 6.2 15100mPa·s No obvious bitter taste 1041 Yellow viscous Fruity aroma 6.3 14050mPa·s No obvious bitter taste 1042 Yellow viscous Fruity aroma 6.2 15775mPa·s No obvious bitter taste 1043 Yellow viscous Fruity aroma 6.0 15325mPa·s No obvious bitter taste 1044 Yellow viscous Fruity aroma 6.1 14100mPa·s No obvious bitter taste 1045 Yellow viscous Fruity aroma 6.2 15850mPa·s No obvious bitter taste
[0093] The results showed that the contents of sucrose, sorbitol and xylitol were within the range of 40% to 50%. The prepared samples were exposed to high temperature of 40°C for 5 days without any significant changes in appearance, smell, pH, viscosity and taste.
[0094] Example 6 Investigation of different types of fragrances and their contents
[0095] Weigh the raw and auxiliary materials according to Table 6-1, and prepare the corresponding samples in the same way as Example 1.
[0096] Table 6-1 Oral gels with different types of fragrances and their contents
[0097]
[0098]
[0099] The appearance and smell of the samples in Table 6-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0100] Table 6-2 Sample test results
[0101] sample Appearance odor pH Viscosity taste 1046 Yellow viscous Fruity aroma 6.3 15300mPa·s No obvious bitter taste 1047 Yellow viscous Fruity aroma 6.2 15000mPa·s No obvious bitter taste 1048 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1049 Yellow viscous Fruity aroma 6.2 15125mPa·s No obvious bitter taste 1050 Yellow viscous Fruity aroma 6.3 15425mPa·s No obvious bitter taste 1051 Yellow viscous Fruity aroma 6.0 15400mPa·s No obvious bitter taste 1052 Yellow viscous Fruity aroma 6.2 15450mPa·s No obvious bitter taste 1053 Yellow viscous Fruity aroma 6.1 15350mPa·s No obvious bitter taste 1054 Yellow viscous Fruity aroma 6.3 15150mPa·s No obvious bitter taste 1055 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste
[0102] The samples in Table 6-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0103] Table 6-3 Test results of samples after 5 days of high temperature reaction
[0104] sample Appearance odor pH Viscosity taste 1046 Yellow viscous Fruity aroma 6.1 15400mPa·s No obvious bitter taste 1047 Yellow viscous Fruity aroma 6.2 15100mPa·s No obvious bitter taste 1048 Yellow viscous Fruity aroma 6.2 15000mPa·s No obvious bitter taste 1049 Yellow viscous Fruity aroma 6.0 15075mPa·s No obvious bitter taste 1050 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1051 Yellow viscous Fruity aroma 6.3 15300mPa·s No obvious bitter taste 1052 Yellow viscous Fruity aroma 6.2 15100mPa·s No obvious bitter taste 1053 Yellow viscous Fruity aroma 6.1 15075mPa·s No obvious bitter taste 1054 Yellow viscous Fruity aroma 6.0 15250mPa·s No obvious bitter taste 1055 Yellow viscous Fruity aroma 6.0 15000mPa·s No obvious bitter taste
[0105] The results showed that when the fragrance content was in the range of 0.1% to 0.5%, the prepared samples had no significant changes in appearance, odor, pH, viscosity, taste, etc. after being exposed to high temperature of 40°C for 5 days.
[0106] Example 7 Investigation of different contents of needle-shaped nystatin
[0107] Weigh the raw and auxiliary materials according to Table 7-1, and prepare the corresponding samples in the same way as Example 1.
[0108] Table 7-1 Needle-shaped nystatin oral gel with different contents
[0109]
[0110] The appearance and smell of the samples in Table 7-1 were observed, and the pH, viscosity, and taste were tested (the testing method was the same as in Example 1). The results are shown in the following table:
[0111] Table 7-2 Sample test results
[0112] sample Appearance odor pH Viscosity taste 1056 Yellow viscous Fruity aroma 6.1 15100mPa·s No obvious bitter taste 1057 Yellow viscous Fruity aroma 6.1 15200mPa·s No obvious bitter taste 1058 Yellow viscous Fruity aroma 6.0 15000mPa·s No obvious bitter taste 1059 Yellow viscous Fruity aroma 6.3 15050mPa·s No obvious bitter taste 1060 Yellow viscous Fruity aroma 6.1 15175mPa·s No obvious bitter taste 1061 Yellow viscous Fruity aroma 6.0 15475mPa·s No obvious bitter taste 1062 Yellow viscous Fruity aroma 6.0 15050mPa·s No obvious bitter taste 1063 Yellow viscous Fruity aroma 6.2 15500mPa·s Slightly bitter
[0113] The samples in Table 7-1 were placed in a 40°C oven and the results of the observations for 5 days are shown in the following table:
[0114] Table 7-3 Test results of samples after 5 days of high temperature reaction
[0115] sample Appearance odor pH Viscosity taste 1056 Yellow viscous Fruity aroma 6.3 15200mPa·s No obvious bitter taste 1057 Yellow viscous Fruity aroma 6.1 15100mPa·s No obvious bitter taste 1058 Yellow viscous Fruity aroma 6.1 15100mPa·s No obvious bitter taste 1059 Yellow viscous Fruity aroma 6.3 15200mPa·s No obvious bitter taste 1060 Yellow viscous Fruity aroma 6.3 15050mPa·s No obvious bitter taste 1061 Yellow viscous Fruity aroma 6.1 15150mPa·s No obvious bitter taste 1062 Yellow viscous Fruity aroma 6.2 15200mPa·s No obvious bitter taste 1063 Yellow viscous Fruity aroma 6.1 15450mPa·s Slightly bitter
[0116] The results showed that when the needle-shaped nystatin content was 2.5%, the prepared sample had a slightly bitter taste. When the needle-shaped nystatin content was in the range of 0.8% to 2%, the prepared sample had no significant changes in appearance, odor, pH, viscosity, taste, etc. after being exposed to high temperature of 40°C for 5 days.
[0117] Example 8: Mouse Animal Experiment
[0118] Comparative Example A1:
[0119] Nystatin tablets (500,000 IU) 1 tablet
[0120] Sodium carboxymethylcellulose suspension (about 5 g) (0.8% suspension)
[0121] Crush the tablets before use and adjust the suspension to 100,000 IU / g
[0122] Specific experiment: 10 mice successfully inoculated with Candida albicans were treated with the above-mentioned Examples 1009, 1010, 1016 and the German marketed drugs and control drugs, and the use and treatment characteristics were compared. The number of Candida albicans in the oral cavity after 14 days of treatment is shown in the following table;
[0123]
[0124] The experimental results show that the nystatin composition of the present invention has good applicability and can ensure local drug concentration. Nystatin inhibits and kills pathogenic microorganisms in lesions while promoting the healing of lesion wounds. It has significantly excellent effects in terms of physicochemical stability, medication compliance, and efficacy factors.
[0125] The above is an explanation of the exemplary embodiments of the present invention. However, the protection scope of the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A nystatin oral gel, characterized in that: The oral gel comprises nystatin, a base and a moisturizer.
2. The oral gel according to claim 1, characterized in that The nystatin crystal is needle-shaped.
3. The oral gel according to claim 1, characterized in that The matrix is hydroxyethyl cellulose, preferably one or more of hydroxyethyl cellulose 250G, hydroxyethyl cellulose 250M, and hydroxyethyl cellulose 250HX, and more preferably hydroxyethyl cellulose 250M.
4. The oral gel according to claim 1, characterized in that The humectant is one or more of glycerol and propylene glycol.
5. The oral gel according to claim 1, characterized in that The mass percentage of nystatin in the oral gel is 0.01% to 5%, preferably 0.5% to 3%, preferably 0.8% to 2%; preferably, the mass percentage of the matrix is 0.01% to 5%, preferably 0.5% to 2%, preferably 0.8% to 1.2%; preferably, the mass percentage of the humectant is 0.01% to 30%, preferably 0.5% to 25%, preferably 1% to 20%, preferably 10% to 20%.
6. The oral gel according to claim 1, characterized in that The oral gel further comprises an antibacterial agent; preferably, the antibacterial agent is selected from one or more of methylparaben, ethylparaben, propylparaben, butylparaben, and sodium methylparaben; preferably, the mass percentage of the antibacterial agent in the total amount is 0.01% to 1.0%, preferably 0.05% to 0.5%, and preferably 0.1% to 0.3%.
7. The oral gel according to claim 1, characterized in that The oral gel further comprises a flavoring agent; preferably, the flavoring agent is selected from one or more of sucrose, sorbitol, and xylitol; preferably, the mass percentage of the flavoring agent in the total amount is 0.01% to 70%, preferably 5% to 65%, preferably 10% to 65%, preferably 20% to 60%, preferably 30% to 60%, and more preferably 40% to 50%.
8. The oral gel according to claim 1, characterized in that The oral gel further comprises a fragrance; preferably, the fragrance is selected from one or more of strawberry flavor, raspberry flavor, banana flavor, orange flavor, cinnamaldehyde, mint, and raspberry flavor; preferably, the mass percentage of the fragrance in the total amount is 0.01% to 1.0%, preferably 0.1% to 0.5%.
9. The oral gel according to claim 1, characterized in that The oral gel also includes purified water.
10. A method for preparing a nystatin oral gel, comprising: The flavoring agent, antibacterial agent and purified water are first prepared into a flavoring solution. After the base is dispersed in the moisturizing agent, it is added into the flavoring solution to swell and disperse. Nystatin is separately dispersed in purified water to form a suspension. The suspension and the fragrance are then stirred or ground and mixed with the base solution to make the nystatin uniformly suspended and dispersed in the base.
11. Use of the oral gel according to any one of claims 1 to 9 in the preparation of a medicament for treating thrush oral disease in infants and young children.
Citation Information
Cited By
Oral gel and application thereof
CN119606873A
